CLINICAL_TRIALS
research
· 2026-04-22
Clinical Trial Update: CHORUS - Comprehensive HHT Outcomes Registry of the United States (Formerly OUR HHT Registry)
Summary
The CHORUS registry (NCT04150822) is an ongoing US outcomes registry for hereditary hemorrhagic telangiectasia (formerly OUR HHT), sponsored by Unity Health Tor…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Unity Health Toronto | Conditions: Hereditary Hemorrhagic Telangiectasia, HHT | Status: ACTIVE_NOT_RECRUITING